Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.24 USD | +9.56% | +8.16% | -80.70% |
Mar. 28 | Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 20 | Tenax Therapeutics Secures Global Rights for Levosimendan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.70% | 7.49M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Tenax Therapeutics, Inc. - Nasdaq
- News Tenax Therapeutics, Inc.
- Tenax Therapeutics : Directors Blanck, Pepin, and Rallis Won't Seek Re-Election to Board